Visunex Medical Systems raised $20 million in a Series B round, which will expand its R&D and manufacturing operations. The company markets a wireless digital imaging system that screens for eye disorders in newborns.
The Fremont, California-based company markets the PanoCam suite of devices, wide-field digital imaging tools for newborns and infants.
The PanoCam LT system comprises an image-capturing device, review software and a color printer, which fit into a suitcase for easy transport. Images and data are transmitted wirelessly between the components and to the cloud.
Its followup, the PanoCam Pro, scored FDA clearance last year, and Visunex plans to launch another device later this year, according to a statement.
"This new round of funding brings the total investment into Visunex Medical to $32 million, and will allow the company to expand manufacturing operations to meet the market demand,” said Visunex CEO Wei Su in the statement. “We will also increase our investment in R&D, including resources, to bring additional products and clinical options through the development pipeline and into the market.”